Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Determination of body composition in patients with resectable pancreatic ductal adenocarcinoma.

Axial contrast-enhanced portal-venous phase CT image at the L3 level of a sarcopenic obese patient (A, 67-year old female, BMI 33 kg/m2, total muscle tissue cross-sectional area 109.2 cm2, skeletal muscle index 39.3 cm2/m2) compared to a non-sarcopenic obese patient (B, 71-year old female, BMI 31 kg/m2, total muscle tissue cross-sectional area 130.4 cm2, skeletal muscle index 47.7 cm2/m2). Marked red: psoas, paraspinal, transverse abdominal, external oblique, internal oblique and rectus abdominis muscles.

More »

Fig 1 Expand

Table 1.

Patient and tumor characteristics comparing sarcopenic and non-sarcopenic patients.

More »

Table 1 Expand

Table 2.

Patient and tumor characteristics comparing sarcopenic obese and non-sarcopenic obese patients.

More »

Table 2 Expand

Table 3.

Body composition data comparing sarcopenic and non-sarcopenic patients.

More »

Table 3 Expand

Table 4.

Overall and sex-specific body composition data.

More »

Table 4 Expand

Fig 2.

Kaplan Meier curve for overall survival in sarcopenic vs. non-sarcopenic patients.

Sarcopenia diminishes overall survival in patients with resectable PDAC (14 vs. 20 months, p = 0.016).

More »

Fig 2 Expand

Fig 3.

Kaplan Meier curve for overall survival in sarcopenic vs. non-sarcopenic male patients.

Sarcopenia diminishes overall survival in male patients with resectable PDAC (15 vs. 25 months, p = 0.023).

More »

Fig 3 Expand

Fig 4.

Kaplan Meier curve for overall survival in sarcopenic vs. non-sarcopenic female patients.

Sarcopenia does not diminish overall survival in female patients with resectable PDAC (14 vs. 20 months, p = 0.378).

More »

Fig 4 Expand

Fig 5.

Kaplan Meier curve for overall survival in obese sarcopenic vs. non-sarcopenic patients (BMI ≥25 kg/m2).

Sarcopenia diminishes overall survival in obese patients with resectable PDAC (14 vs. 23 months, p = 0.007).

More »

Fig 5 Expand

Fig 6.

Kaplan Meier curve for overall survival in normal/underweight sarcopenic vs. non-sarcopenic patients (BMI <25 kg/m2).

Sarcopenia does not diminish overall survival in normal/underweight patients with resectable PDAC (14 vs. 16 months, p = 0.679).

More »

Fig 6 Expand

Table 5.

Kaplan Meier estimates for overall survival.

More »

Table 5 Expand

Table 6.

Uni- and multivariable Cox-Regression analyses and interaction models for overall survival.

More »

Table 6 Expand